RCKT Rocket Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RCKT

Price (delayed)

$3.02

Market cap

$331.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.16

Enterprise value

$129.99M

?
Relative Growth: Rel. Growth: 28
Relative Strength: Rel. Strength: 25
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 24
Highlights
Rocket Pharmaceuticals's EPS has soared by 94% YoY and by 91% from the previous quarter
RCKT's net income has soared by 93% YoY and by 92% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.rocketpharma.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of RCKT

RCKT stock price

How has the Rocket Pharmaceuticals stock price performed over time
Intraday
-9.85%
1 week
-13.22%
1 month
-13.96%
1 year
-2.58%
YTD
-13.96%
QTD
-11.7%

Financial performance

How have Rocket Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$191.64M
Net income
-$17.25M
Gross margin
N/A
Net margin
N/A
RCKT's net income has soared by 93% YoY and by 92% from the previous quarter
The operating income has grown by 28% YoY and by 11% from the previous quarter

Price vs fundamentals

How does RCKT's price correlate with its fundamentals

Growth

What is Rocket Pharmaceuticals's growth rate over time

Valuation

What is Rocket Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
43.78
EV/Sales
N/A
Rocket Pharmaceuticals's EPS has soared by 94% YoY and by 91% from the previous quarter
The stock's price to book (P/B) is 66% less than its 5-year quarterly average of 2.9 and 24% less than its last 4 quarters average of 1.3
The equity has surged by 55% since the previous quarter and by 4.1% year-on-year

Efficiency

How efficient is Rocket Pharmaceuticals business performance
The ROIC has soared by 96% from the previous quarter and by 95% YoY
The return on assets has surged by 92% since the previous quarter and by 91% year-on-year
RCKT's ROE has soared by 92% from the previous quarter and by 91% YoY

Dividends

What is RCKT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RCKT.

Financial health

How did Rocket Pharmaceuticals financials performed over time
The quick ratio has surged by 53% since the previous quarter and by 45% year-on-year
Rocket Pharmaceuticals's current ratio has surged by 51% QoQ and by 45% YoY
The debt is 93% smaller than the equity
The equity has surged by 55% since the previous quarter and by 4.1% year-on-year
Rocket Pharmaceuticals's debt to equity has decreased by 30% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.